Answer
Based on a population pharmacokinetic analysis, mogamulizumab’s geometric mean elimination half-life is 17 days, with a coefficient of variation of 65.5%.
Sources for this answer
- Poteligeo 4 mg/mL, Concentrate for Solution for InfusionKyowa Kirin Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 9Document updated
Sources checked